Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,476,643 papers from all fields of science
Search
Sign In
Create Free Account
Prostatic Hyperplasia
Known as:
PROSTATE, HYPERPLASIA, NODULAR
, Hyperplasia, Prostatic
, Prostatic Hyperplasia [Disease/Finding]
Expand
Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
0.5 ML Leuprolide Acetate 60 MG/ML Prefilled Syringe [Eligard]
1 ML Leuprolide Acetate 11.25 MG/ML Prefilled Syringe [Lupron]
1 ML Leuprolide Acetate 7.5 MG/ML Prefilled Syringe [Lupron]
1.5 ML Leuprolide Acetate 20 MG/ML Prefilled Syringe [Lupron]
Expand
Narrower (1)
Prostatic stromal proliferation of uncertain malignant potential
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Medical Treatment of Benign Prostatic Hyperplasia
C. Noble
2010
Corpus ID: 58325512
Benign prostatic hyperplasia (BPH) is the most common benign tumour in men and its prevalence increases with age. Despite being…
Expand
2009
2009
Prostatic Injection of Botulinum A Toxin: An Alternative Treatment for Benign Prostatic Hyperplasia
A. Yarmohammadi
,
Mahmood Molaei
,
S. Yaghoubi
2009
Corpus ID: 73371734
Introduction: We examined the clinical effectiveness of prostate injection of botulinum A toxin in the treatment of BPH. Methods…
Expand
2009
2009
Drug Therapy for Benign Prostatic Hyperplasia
L. Hui
2009
Corpus ID: 76608977
Benign prostatic hyperplasia(BPH) is one of common diseases in old men.Now,its main treatment is surgery.Although its effect is…
Expand
2007
2007
Тромбоэмболические осложнения у больных с различными злокачественными новообразованиями в послеоперационном периоде
С. А. Ходоренко
,
Анна Николаевна Шилова
,
З. С. Баркаган
,
Александр Федорович Лазарев
,
Е. Ф. Котовщикова
,
Е. И. Буевич
2007
Corpus ID: 74943670
We studied 78 cases with venous thromboembolism and the related lethality after 9,899 surgical interventions during a period when…
Expand
2006
2006
Discontinuation of an Alpha-1 Blocker or 5-Alpha-Reductase Inhibitor after Combination Medical Treatment in Patients with Benign Prostatic Hyperplasia
Yuan-Ming Liaw
,
H. Kuo
2006
Corpus ID: 58526291
Objective: To investigate changes in prostatic volume, uroflow measurements, and clinical benign prostatic hyperplasia (BPH…
Expand
2005
2005
Valores de referencia del antígeno prostático específico
M. Blanes
,
G. Velázquez
,
Margarita Cabral
2005
Corpus ID: 178955051
En el presente estudio se determinaron los valores de referencia del PAS (antigeno prostatico especifico) en individuos en estado…
Expand
2005
2005
Observation on therapeutic effect in treatment of prostate hyperplasia by needle-warming moxibustion
Xiao Yuan-hui
2005
Corpus ID: 73285893
With Shenshu (BL 23), Ciliao (BL 32), Pangguangshu (BL 28), Huiyin (CV 1) and Zhibian (BL 54) as the main acupoints, and with…
Expand
2003
2003
5-α-Reductase Inhibitors Prevent the Progression of Benign Prostatic Hyperplasia
C. Roehrborn
2003
Corpus ID: 71018764
Lower urinary tract symptoms (LUTS) associated with clinical benign prostatic hyperplasia (BPH) are a common occurrence in aging…
Expand
1999
1999
Prevalence of Benign Prostatic Hyperplasia in Jeong-Eup Area: Community-based Study
T. G. Chung
,
Jinsoo Chung
,
M. Lee
,
H. Ahn
1999
Corpus ID: 79303124
1987
1987
Primary atypical epithelial hyperplasia of prostate gland: a premalignant lesion?
M. Tannenbaum
,
M. Droller
World journal of urology
1987
Corpus ID: 11187531
SummaryAtypical primary hyperplasia (or dysplasia) of the prostate gland is based on both histological and cytological features…
Expand